Quick Answer
EXOZYMES INC. reported Operating Income of -$9.72 million for fiscal year 2025.
EXOZYMES INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$9.72M | -63.8% |
| 2024 | -$5.93M | -230.3% |
| 2023 | -$1.80M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.52M | -56.5% | +1.0% |
| June 30, 2025 | -$2.55M | -91.8% | -30.6% |
| March 31, 2025 | -$1.95M | -93.4% | -21.0% |
| September 30, 2024 | -$1.61M | -311.3% | -21.3% |
| June 30, 2024 | -$1.33M | — | -31.7% |
| March 31, 2024 | -$1.01M | — | -157.4% |
| September 30, 2023 | -$391.8K | — | — |
- EXOZYMES INC. showed a decrease of -63.8% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, EXOZYMES INC.’s operating income has declined by 440.9% (from -$1.80 million to -$9.72 million).
- The most recent figure is from EXOZYMES INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: